|
|
|
| Webinar: Automating cell therapy manufacturing without redesigning established workflows | As cell therapy programs advance toward the clinic, manufacturers must balance automation with process consistency and flexibility. In this webinar, Cytiva experts will showcase how the Sefia™ cell therapy manufacturing platform enables closed, automated processing without redesigning existing workflows. Attendees will learn practical strategies to reduce operational risk, preserve biological performance, and prepare scalable, GMP-ready manufacturing processes. Click here to learn more. |
|
|
|
|
A conversation between Gourav Pandey, Takeda, and Life Science Connect's Jon O'Connell | A Takeda quality executive demonstrates how a team of AI agents uses synthetic data to provide decision support ahead of CDMO audits. | |
|
|
| Efficient Plasmid Linearization: Type I & II Enzymes | Poster | By Charlie Fan, Delicia Henriques, Ph.D., Justin Chen, Philemon Asfeha, et al., ProBio | Advanced plasmid linearization improves transfection efficiency and gene expression, delivering high-purity DNA with rapid turnaround, low endotoxin, and scalable processes for cell and gene therapy applications. |
|
|
|
|
|
|
| The Growing Strategic Importance Of CDMOs In CGT | E-Book | Catalent | Discover how advanced manufacturing platforms, integrated analytics, and accelerated development strategies are helping overcome the scalability, supply chain, and operational challenges. |
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
